Release Date: 04/02/20 14:37 Summary: Quarterly Update - December 2019 Price Sensitive: No Download Document 1.47MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%